Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Angiogenesis
|
April 1, 2011
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
Puja Sapra, Patricia Kraft, Fabio Pastorino, et al.
Molecular Cancer Therapeutics
|
July 29, 2016
Biodistribution and Targeting of Anti-5T4 Antibody-Drug Conjugate Using Fluorescence Molecular Tomography
Anand Giddabasappa, Vijay R Gupta, Rand Norberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2010
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor
Fabio Pastorino, Monica Loi, Puja Sapra, et al.
Bioconjugate Chemistry
|
March 29, 2008
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers
Hong Zhao, Belen Rubio, Puja Sapra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2005
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys
Puja Sapra, Rhona Stein, Jennifer Pickett, et al.
Neoplasia (New York, N.Y.)
|
November 25, 2017
Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia
Cathy C Zhang, Zhengming Yan, Bernadette Pascual, et al.
Bioconjugate Chemistry
|
July 17, 2015
Preclinical Development of an anti-5T4 Antibody-Drug Conjugate: Pharmacokinetics in Mice, Rats, and NHP and Tumor/Tissue Distribution in Mice
Mauricio Leal, JoAnn Wentland, Xiaogang Han, et al.
Plos One
|
May 31, 2017
Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
Sujiet Puthenveetil, Haiyin He, Frank Loganzo, et al.
Mabs
|
August 4, 2021
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors
Changhua Ji, Marc D Roy, Jonathan Golas, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Angiogenesis
|
April 1, 2011
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
Puja Sapra, Patricia Kraft, Fabio Pastorino, et al.
Molecular Cancer Therapeutics
|
July 29, 2016
Biodistribution and Targeting of Anti-5T4 Antibody-Drug Conjugate Using Fluorescence Molecular Tomography
Anand Giddabasappa, Vijay R Gupta, Rand Norberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2010
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor
Fabio Pastorino, Monica Loi, Puja Sapra, et al.
Bioconjugate Chemistry
|
March 29, 2008
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers
Hong Zhao, Belen Rubio, Puja Sapra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2005
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys
Puja Sapra, Rhona Stein, Jennifer Pickett, et al.
Neoplasia (New York, N.Y.)
|
November 25, 2017
Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia
Cathy C Zhang, Zhengming Yan, Bernadette Pascual, et al.
Bioconjugate Chemistry
|
July 17, 2015
Preclinical Development of an anti-5T4 Antibody-Drug Conjugate: Pharmacokinetics in Mice, Rats, and NHP and Tumor/Tissue Distribution in Mice
Mauricio Leal, JoAnn Wentland, Xiaogang Han, et al.
Plos One
|
May 31, 2017
Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
Sujiet Puthenveetil, Haiyin He, Frank Loganzo, et al.
Mabs
|
August 4, 2021
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors
Changhua Ji, Marc D Roy, Jonathan Golas, et al.
Page
of 6